Clinical Trial Update: OptimizeD Pilot Study [Phase 3]

View source ↗

Summary

Phase 3 pilot study update for OptimizeD completed, investigating depression and depressive disorder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Depressive Disorder
• Major Depressive Disorder

Snippet

Sponsor: Harvard Medical School (HMS and HSDM) | Conditions: Depression, Depressive Disorder | Phase 3 | Status: COMPLETED